LivaNova (LIVN) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
LivaNova · Health Care · ref. ETF XLV · 51 calls · price $76.37
What the company does: LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services.
📈 LivaNova (LIVN) stock price
$76.37+44.7% over range
Oct 14, 25low $49.57 · high $85.32Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
86% recommend buying · 7 analysts
📊 JPI status : LivaNova has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 LIVN price target & analyst consensus — price $76.37
The price target · all analysts combined (7 targets)
Highest target · 1 firm of 7$105+37.5%
Median target · of 7 targets$92+20.5%
Lowest target · 1 firm of 7$76-0.5%
Current price$76.37
Where these 7 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
686%
$81 ↔ $105
Below
114%
$76
⭐ What the most reliable analysts say
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
The consensus · 7 ratings (last 6 months)
Strong Buy00%
Buy686%
Hold114%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 LIVN price target all
All 51 calls, one by one, with our verdict on each firm.
→ See all 51 targets, analyst by analyst💡 The best analysts on LIVN most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in LIVN? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about LivaNova? The JPI assistant answers using our backtest data.
📈 LivaNova fundamentals: valuation, margins & growth › open the full page
P/E 22.6Net margin 12.8 %Revenue growth +10.8 %Cheap for the growth
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. -8 %
2023
Rev +13%
2024
Rev +9%Profit +261%
2025
Rev +11%Profit −484%
🔎 Detailed analyses
✅ Historical analyst reliability on LIVN
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Jefferies ↗ | 100% | +70.7% | 3 |
| Baird ↗ | 67% | +21.1% | 6 |
| Needham ↗ | 59% | +12.5% | 27 |
| Wolfe Research ↗ | 50% | +10.2% | 2 |
| Stifel ↗ | 33% | +8.1% | 6 |
| Mizuho ↗ | 33% | -3.2% | 6 |
| Piper Sandler ↗ | 33% | -12.6% | 3 |
| Goldman Sachs ↗ | 20% | -1.4% | 5 |
📊 What $1,000 invested in LivaNova would be worth › open the full page
In short — $1,000 invested in LivaNova 10 years ago would be worth $1,385 today, i.e. +3%/yr on average. Best year: 2017 (+78%), worst: 2022 (-36%). Price performance, excluding dividends.
If I'd invested $1,000 in LivaNova
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,776 | +78% |
| 3 years ago | $1,481 | +48% |
| 5 years ago | $1,242 | +24% |
Return by year (LivaNova)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +34% | $1,336 (+34%) |
| 2025 | +33% | $1,776 (+78%) |
| 2024 | -10% | $1,589 (+59%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on LivaNova
Loading news…
📋 All analyst calls on LIVN
Filtered on — · ✕ show all
▲ Overweight · 🎯$105
Price at call : $75.93 — upside +38%
Today : $76.37 — upside +37%
🎯 on LIVN : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Oct 7, 27
matures : Oct 7, 27
Piper Sandler ↗
Sep 2, 26
▲ Overweight · 🎯$90
Price at call : $81.2 — upside +11%
Today : $76.37 — upside +18%
🎯 on LIVN : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Sep 2, 27
matures : Sep 2, 27
▲ Buy · 🎯$93
Price at call : $75.78 — upside +23%
Today : $76.37 — upside +22%
🎯 on LIVN : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
in progress (365j)
matures : Aug 5, 27
matures : Aug 5, 27
▲ Outperform · 🎯$95
Price at call : $81.79 — upside +16%
Today : $76.37 — upside +24%
🎯 on LIVN : 50% (4 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : Jul 15, 27
matures : Jul 15, 27
Freedom Capital Markets
Jul 1, 26
■ Hold neutral · not a buy · 🎯$81
Price at call : $82.48 — gap to target -2%
Today : $76.37 — gap to target +6%
🎯 on LIVN : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Jul 1, 27
matures : Jul 1, 27
▲ Overweight · 🎯$92
Price at call : $78.71 — upside +17%
Today : $76.37 — upside +20%
🎯 on LIVN : no call matured yet · 📊 on Health : 31.9% · -11.8% (47 calls)
in progress (365j)
matures : Jun 22, 27
matures : Jun 22, 27
■ Equal-Weight neutral · not a buy · 🎯$76
Price at call : $71.86 — gap to target +6%
Today : $76.37 — gap to target -0%
🎯 on LIVN : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
▲ Outperform · 🎯$90
Price at call : $70.93 — upside +27%
Today : $76.37 — upside +18%
🎯 on LIVN : 50% (4 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
See the other 43 calls, newest to oldest
▲ Outperform · 🎯$76
Price at call : $70.93 — upside +7%
Today : $76.37 — upside -0%
🎯 on LIVN : 100% (3 calls matureds) · 📊 on Health : 48.1% · +0.7% (77 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
■ Equal-Weight neutral · not a buy · 🎯$73
Price at call : $70.27 — gap to target +4%
Today : $76.37 — gap to target -4%
🎯 on LIVN : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Feb 27, 27
matures : Feb 27, 27
▲ Buy · 🎯$81
Price at call : $71 — upside +14%
Today : $76.37 — upside +6%
🎯 on LIVN : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
■ Equal-Weight neutral · not a buy · 🎯$67
Price at call : $62.38 — gap to target +7%
Today : $76.37 — gap to target -12%
🎯 on LIVN : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Jan 9, 27
matures : Jan 9, 27
▲ Buy · 🎯$70
Price at call : $64.62 — upside +8%
Today : $76.37 — upside -8%
🎯 on LIVN : 50% (2 calls matureds) · 📊 on Health : 48% · +12.3% (100 calls)
in progress (365j)
matures : Jan 7, 27
matures : Jan 7, 27
▲ Overweight · 🎯$81
Price at call : $62.82 — upside +29%
Today : $76.37 — upside +6%
🎯 on LIVN : no call matured yet · 📊 on Health : 31.9% · -11.8% (47 calls)
in progress (365j)
matures : Dec 19, 26
matures : Dec 19, 26
▲ Outperform · 🎯$72
Price at call : $63.08 — upside +14%
Today : $76.37 — upside -6%
🎯 on LIVN : 50% (4 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : Dec 17, 26
matures : Dec 17, 26
▲ Outperform · 🎯$70
Price at call : $55.2 — upside +27%
Today : $76.37 — upside -8%
🎯 on LIVN : 50% (4 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : Nov 13, 26
matures : Nov 13, 26
▲ Outperform · 🎯$70
Price at call : $55.2 — upside +27%
Today : $76.37 — upside -8%
🎯 on LIVN : 100% (3 calls matureds) · 📊 on Health : 48.1% · +0.7% (77 calls)
in progress (365j)
matures : Nov 13, 26
matures : Nov 13, 26
▲ Outperform · 🎯$63
Price at call : $50.45 — upside +25%
Today : $76.37 — upside -18%
🎯 on LIVN : 100% (3 calls matureds) · 📊 on Health : 48.1% · +0.7% (77 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
▲ Buy · 🎯$64
Price at call : $56.59 — upside +13%
Today : $76.37 — upside -16%
Expected +13% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on LIVN : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
+43.5%
stock +43% · XLV +27%
matured Sep 3, 26
■ Equal-Weight neutral · not a buy · 🎯$58
Price at call : $55.9 — gap to target +4%
Today : $76.37 — gap to target -24%
🎯 on LIVN : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Aug 21, 26
matures : Aug 21, 26
Wolfe Research ↗
May 20, 25
▲ Outperform · 🎯$60
Price at call : $43.66 — upside +37%
Today : $76.37 — upside -21%
Expected +37% · Actual +69% · Reason (≥ +15%) : ✓ Yes
🎯 on LIVN : 100% (1 call matured) · 📊 on Health : 46.2% · +2.9% (13 calls)
+68.7%
stock +69% · XLV +13%
matured May 20, 26
▲ Buy · 🎯$64
Price at call : $44.06 — upside +45%
Today : $76.37 — upside -16%
Expected +45% · Actual +64% · Reason (≥ +15%) : ✓ Yes
🎯 on LIVN : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
+64.4%
stock +64% · XLV +11%
matured May 13, 26
■ Equal-Weight neutral · not a buy · 🎯$55
Price at call : $44.06 — gap to target +25%
Today : $76.37 — gap to target -28%
🎯 on LIVN : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : May 8, 26
matures : May 8, 26
▲ Outperform · 🎯$61
Price at call : $44.07 — upside +38%
Today : $76.37 — upside -20%
Expected +38% · Actual +63% · Reason (≥ +15%) : ✓ Yes
🎯 on LIVN : 100% (3 calls matureds) · 📊 on Health : 48.1% · +0.7% (77 calls)
+63.1%
stock +63% · XLV +7%
matured May 8, 26
▲ Buy · 🎯$64
Price at call : $41.41 — upside +55%
Today : $76.37 — upside -16%
Expected +55% · Actual +51% · Reason (≥ +15%) : ✓ Yes
🎯 on LIVN : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
+50.8%
stock +51% · XLV +2%
matured Mar 17, 26
■ Equal-Weight neutral · not a buy · 🎯$56
Price at call : $39.17 — gap to target +43%
Today : $76.37 — gap to target -27%
🎯 on LIVN : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Mar 7, 26
matures : Mar 7, 26
Goldman Sachs ↗
Mar 3, 25
▲ Buy · 🎯$55
Price at call : $41.56 — upside +32%
Today : $76.37 — upside -28%
Expected +32% · Actual +57% · Reason (≥ +15%) : ✓ Yes
🎯 on LIVN : 50% (2 calls matureds) · 📊 on Health : 59.5% · +16.1% (111 calls)
+57.0%
stock +57% · XLV +6%
matured Mar 3, 26
▲ Outperform · 🎯$60
Price at call : $40.93 — upside +47%
Today : $76.37 — upside -21%
Expected +47% · Actual +72% · Reason (≥ +15%) : ✓ Yes
🎯 on LIVN : 50% (4 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
+72.5%
stock +72% · XLV +9%
matured Feb 26, 26
▲ Buy · 🎯$60
Price at call : $41.45 — upside +45%
Today : $76.37 — upside -21%
Expected +45% · Actual +71% · Reason (≥ +15%) : ✓ Yes
🎯 on LIVN : 50% (2 calls matureds) · 📊 on Health : 48% · +12.3% (100 calls)
+71.3%
stock +71% · XLV +6%
matured Feb 26, 26
▲ Buy · 🎯$64
Price at call : $41.45 — upside +54%
Today : $76.37 — upside -16%
Expected +54% · Actual +71% · Reason (≥ +15%) : ✓ Yes
🎯 on LIVN : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
+71.3%
stock +71% · XLV +6%
matured Feb 26, 26
▲ Buy · 🎯$75
Price at call : $50.53 — upside +48%
Today : $76.37 — upside -2%
Expected +48% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on LIVN : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
+26.5%
stock +26% · XLV +5%
matured Jan 28, 26
▲ Buy · 🎯$75
Price at call : $51.75 — upside +45%
Today : $76.37 — upside -2%
Expected +45% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on LIVN : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
+22.3%
stock +22% · XLV +9%
matured Nov 25, 25
▲ Buy · 🎯$75
Price at call : $53.58 — upside +40%
Today : $76.37 — upside -2%
Expected +40% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
+3.0%
stock +3% · XLV +4%
matured Nov 12, 25
▲ Outperform · 🎯$70
Price at call : $51.13 — upside +37%
Today : $76.37 — upside -8%
Expected +37% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 50% (4 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
+2.8%
stock +3% · XLV -2%
matured Oct 31, 25
▲ Outperform · 🎯$72
Price at call : $51.62 — upside +39%
Today : $76.37 — upside -6%
Expected +39% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 100% (3 calls matureds) · 📊 on Health : 48.1% · +0.7% (77 calls)
+2.0%
stock +2% · XLV -2%
matured Oct 31, 25
▲ Buy · 🎯$75
Price at call : $51.62 — upside +45%
Today : $76.37 — upside -2%
Expected +45% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
+2.0%
stock +2% · XLV -2%
matured Oct 31, 25
Goldman Sachs ↗
Oct 4, 24
▲ Buy · 🎯$65
Price at call : $53.83 — upside +21%
Today : $76.37 — upside -15%
Expected +21% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 50% (2 calls matureds) · 📊 on Health : 59.5% · +16.1% (111 calls)
-2.2%
stock -2% · XLV -5%
matured Oct 4, 25
▲ Outperform · 🎯$66
Price at call : $51 — upside +29%
Today : $76.37 — upside -14%
Expected +29% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 100% (3 calls matureds) · 📊 on Health : 48.1% · +0.7% (77 calls)
+6.9%
stock +7% · XLV -12%
matured Sep 17, 25
■ Neutral neutral · not a buy · 🎯$55
Price at call : $50.24 — gap to target +9%
Today : $76.37 — gap to target -28%
🎯 on LIVN : 100% (3 calls matureds) · 📊 on Health : 48.1% · +0.7% (77 calls)
in progress (365j)
matures : Aug 28, 25
matures : Aug 28, 25
■ Neutral neutral · not a buy · 🎯$55
Price at call : $48.32 — gap to target +14%
Today : $76.37 — gap to target -28%
🎯 on LIVN : 100% (3 calls matureds) · 📊 on Health : 48.1% · +0.7% (77 calls)
in progress (365j)
matures : Aug 1, 25
matures : Aug 1, 25
▲ Buy · 🎯$75
Price at call : $48.32 — upside +55%
Today : $76.37 — upside -2%
Expected +55% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
-14.9%
stock -15% · XLV -13%
matured Jul 31, 25
▲ Buy · 🎯$72
Price at call : $53.61 — upside +34%
Today : $76.37 — upside -6%
Expected +34% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 50% (2 calls matureds) · 📊 on Health : 48% · +12.3% (100 calls)
-18.9%
stock -19% · XLV -10%
matured Jul 25, 25
▲ Buy · 🎯$72
Price at call : $53.38 — upside +35%
Today : $76.37 — upside -6%
Expected +35% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
-13.3%
stock -13% · XLV -8%
matured Jun 6, 25
▲ Buy · 🎯$80
Price at call : $62.92 — upside +27%
Today : $76.37 — upside +5%
Expected +27% · Actual -42% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 50% (4 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
-41.5%
stock -42% · XLV -1%
matured May 2, 25
■ Neutral neutral · not a buy · 🎯$66
Price at call : $62.92 — gap to target +5%
Today : $76.37 — gap to target -14%
🎯 on LIVN : 100% (3 calls matureds) · 📊 on Health : 48.1% · +0.7% (77 calls)
in progress (365j)
matures : May 2, 25
matures : May 2, 25
▲ Buy · 🎯$72
Price at call : $62.92 — upside +14%
Today : $76.37 — upside -6%
Expected +14% · Actual -42% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
-41.5%
stock -42% · XLV -1%
matured May 1, 25
▲ Buy · 🎯$75
Price at call : $55.94 — upside +34%
Today : $76.37 — upside -2%
Expected +34% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 50% (4 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
-30.0%
stock -30% · XLV -2%
matured Mar 27, 25
▲ Buy · 🎯$72
Price at call : $56.28 — upside +28%
Today : $76.37 — upside -6%
Expected +28% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 67% (12 calls matureds) · 📊 on Health : 47.2% · +2.5% (142 calls)
-29.8%
stock -30% · XLV +1%
matured Mar 20, 25
■ Equal-Weight neutral · not a buy · 🎯$61
Price at call : $55.09 — gap to target +11%
Today : $76.37 — gap to target -20%
🎯 on LIVN : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Feb 26, 25
matures : Feb 26, 25
■ Equal-Weight neutral · not a buy · 🎯$61
Price at call : $55.97 — gap to target +9%
Today : $76.37 — gap to target -20%
🎯 on LIVN : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Feb 25, 25
matures : Feb 25, 25
Frequently asked questions
Should I buy LivaNova stock?
This isn't buy advice. For LivaNova, the analyst consensus is "Buy", with an average price target of $92.00 (+20% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (3 calls tracked on LivaNova). We show the numbers — you decide.
Is it too late to buy LivaNova? How high can it go?
The most bullish analyst target on LivaNova is $105 (+37% above today's price); the average is $92.00. That's the upside they see. Check how reliable those analysts have actually been on LivaNova on our site before trusting it.
Is LivaNova still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 8 analysts have a real record on LivaNova, the best hitting 100% over 3 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in LivaNova? The case for and against
The arguments for and against, one by one, from the numbers: why invest in LIVN (and why hesitate).
What has LivaNova's past performance been?
Historical returns and a "how much if I had invested" calculator: LIVN performance & returns.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX